A federal judge in Texas heard arguments Wednesday in a case that could potentially threaten the most common form of abortion in the United States. U.S. District Judge Matthew Kacsmaryk heard arguments from the Alliance Defending Freedom lawyers to revoke or suspend the approval of the abortion medication mifepristone, which has been used by millions of American women for over two decades. Judge Kacsmaryk did not issue a ruling Wednesday, but the outcome of the case could have far-reaching implications for women’s reproductive rights in the United States.
Posts tagged as “FDA”
Fourteen Democratic governors have called on major pharmacy retail companies to clarify their plans to dispense mifepristone, a drug used for medication abortion, in response to recent media reports. This call has been met with opposition from a coalition of anti-abortion groups, who have requested a preliminary injunction to take mifepristone off the market nationwide. If access to mifepristone is halted, it could affect millions of individuals in states where medication abortion is lawfully dispensed. The issue of access to abortion medication has become increasingly politicized, and it remains to be seen how the pharmacy retail companies will respond.
Key takeaways: The FDA released new standards that could help more women detect breast cancer earlier. The new rules will require mammogram providers to notify…
At the Conservative Political Action Conference (CPAC) on Saturday, former President Donald Trump and Florida Governor Ron DeSantis gave speeches that provided a glimpse into the potential 2024 Republican nomination race. Trump offered his usual rhetoric, while DeSantis took a more measured approach. Meanwhile, on "Face the Nation," a variety of guests discussed the current state of the Republican Party, as it struggles to define itself in the face of a growing list of issues on Capitol Hill. It remains to be seen how the 2024 Republican nomination race will play out, but Trump and DeSantis’s CPAC speeches have provided a glimpse into the potential future of the party.
The US Food and Drug Administration (FDA) is close to approving the first nation's RSV vaccine, developed by Pfizer, which has been shown to reduce the risk of illness from RSV by as much as 86%. The Vaccines and Related Biological Products Advisory Committee voted 7-4 in favor of the vaccine, despite some safety concerns. If approved, the vaccine would be the first of its kind in the US and provide a much-needed protection against RSV for older adults.
The FDA has released draft rules allowing plant-based drinks to label themselves as "milk" and providing voluntary extra nutrition labels to note when the drinks have lower levels of certain nutrients than dairy milk. The rules are open for public comment until April 13, 2021, and will provide clarity for consumers and producers when the final rule is issued.
The FDA advisory committee has voted unanimously to recommend that a nasal spray version of naloxone, a medication used to reverse opioid overdoses, be sold over-the-counter. If approved, the drug would be more widely available and accessible to those who need it, potentially helping to save lives and reduce the number of opioid-related deaths. The FDA is expected to make a decision on the request in the coming weeks.
The US Centers for Disease Control and Prevention (CDC) is warning people to stop using the over-the-counter eye drops, EzriCare Artificial Tears, due to an outbreak of drug-resistant infections of Pseudomonas aeruginosa. The CDC has received reports of 55 infections in 12 states, including one fatality, and Global Pharma Healthcare is issuing a recall of the product. The FDA is continuing to investigate the source of the contamination and the CDC is urging people to seek medical attention if they have used the product and are experiencing any symptoms.